These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 30768180)

  • 41. Characterisation of
    Lesiak-Markowicz I; Walochnik J; Stary A; Fürnkranz U
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293276
    [No Abstract]   [Full Text] [Related]  

  • 42. Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women.
    Kissinger P; Secor WE; Leichliter JS; Clark RA; Schmidt N; Curtin E; Martin DH
    Clin Infect Dis; 2008 Apr; 46(7):994-9. PubMed ID: 18444815
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atomic Structure of the Trichomonas vaginalis Double-Stranded RNA Virus 2.
    Stevens A; Muratore K; Cui Y; Johnson PJ; Zhou ZH
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785622
    [No Abstract]   [Full Text] [Related]  

  • 44. Molecular characterization of Egyptian Trichomonas vaginalis clinical isolates by HSP70 restriction fragment length polymorphism.
    Hussien EM; El-Sayed HZ; El-Moamly AA; Helmy MM; Shaban MM
    J Egypt Soc Parasitol; 2005 Aug; 35(2):699-710. PubMed ID: 16083077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytidine nucleoside analog is an effective antiviral drug against Trichomonasvirus.
    Narayanasamy RK; Rada P; Zdrha A; van Ranst M; Neyts J; Tachezy J
    J Microbiol Immunol Infect; 2022 Apr; 55(2):191-198. PubMed ID: 34479802
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative in vitro cytotoxic effects of ornidazole, metronidazole and ciprofloxacin against Trichomonas vaginalis trophozoites.
    Inceboz T; Inceboz U; Ozturk S
    J Chemother; 2004 Oct; 16(5):459-62. PubMed ID: 15565912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Mycoplasma hominis symbiosis and Trichomonas vaginalis metronidazole resistance].
    Wang PJ; Xie CB
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2012 Jun; 30(3):210-3. PubMed ID: 23072138
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Therapeutic aspects of trichomoniasis].
    Vukićević J; Jankicević J
    Srp Arh Celok Lek; 2003; 131(3-4):156-61. PubMed ID: 14608880
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis.
    Dunne RL; Dunn LA; Upcroft P; O'Donoghue PJ; Upcroft JA
    Cell Res; 2003 Aug; 13(4):239-49. PubMed ID: 12974614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Concordance between genetic relatedness and phenotypic similarities of Trichomonas vaginalis strains.
    Hampl V; Vanácová S; Kulda J; Flegr J
    BMC Evol Biol; 2001; 1():11. PubMed ID: 11734059
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distribution of genotypes in relation to metronidazole susceptibility patterns in Trichomonas vaginalis isolated from South African pregnant women.
    Mabaso N; Abbai N
    Parasitol Res; 2021 Jun; 120(6):2233-2241. PubMed ID: 34002261
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metronidazole resistance in Trichomonas vaginalis from highland women in Papua New Guinea.
    Upcroft JA; Dunn LA; Wal T; Tabrizi S; Delgadillo-Correa MG; Johnson PJ; Garland S; Siba P; Upcroft P
    Sex Health; 2009 Dec; 6(4):334-8. PubMed ID: 19917203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis.
    Lossick JG; Müller M; Gorrell TE
    J Infect Dis; 1986 May; 153(5):948-55. PubMed ID: 3486237
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.
    Cudmore SL; Delgaty KL; Hayward-McClelland SF; Petrin DP; Garber GE
    Clin Microbiol Rev; 2004 Oct; 17(4):783-93, table of contents. PubMed ID: 15489348
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    Ghosh AP; Aycock C; Schwebke JR
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29439963
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis.
    Crowell AL; Sanders-Lewis KA; Secor WE
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1407-9. PubMed ID: 12654679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Susceptibility of Trichomonas vaginalis strains to metronidazole: response to treatment.
    Ralph ED; Darwish R; Austin TW; Smith EA; Pattison FL
    Sex Transm Dis; 1983; 10(3):119-22. PubMed ID: 6359490
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Killing of Trichomonas vaginalis by complement-mediated lysis is not associated with the presence of Trichomonas vaginalis virus.
    Shaio MF; Lin PR; Lee CS
    Int J Parasitol; 1993 Aug; 23(5):675-80. PubMed ID: 8225773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro activity of nitazoxanide against some metronidazole-resistant and susceptible Trichomonas vaginalis isolates.
    Abdel-Magied AA; Hammouda MM; Mosbah A; El-Henawy AA
    J Infect Chemother; 2017 Apr; 23(4):230-233. PubMed ID: 28131737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spontaneous resolution of
    Van Gerwen OT; Aaron KJ; Schroeder J; Kissinger PJ; Muzny CA
    Sex Transm Infect; 2024 Oct; 100(7):450-453. PubMed ID: 38937096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.